-
Je něco špatně v tomto záznamu ?
Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases
V. Liska, A. Sutnar, LH. Jr, J. Vrzalova, V. Treska, T. Skalicky, M. Pesta, S. Kormunda, J. Finek, M. Rousarova, O. Topolcan,
Jazyk angličtina Země Slovensko
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
NS10230
MZ0
CEP - Centrální evidence projektů
PubMed
22394042
DOI
10.4149/bll_2012_025
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- kolorektální nádory patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- matrixové metaloproteinasy krev MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádorové biomarkery krev MeSH
- nádory jater diagnóza sekundární chirurgie MeSH
- prognóza MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- tkáňové inhibitory metaloproteinas krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
OBJECTIVES: Classical and proliferative tumour markers and matrix metalloproteinases and their tissue inhibitors reflect the features of malignancy and are useful in prediction of prognosis in patients with colorectal liver metastases. There is very limited information about their physiological functions during regeneration and healing of liver parenchyma after any type of liver surgery for malignancy. METHODS: The presented study included the patients, who underwent following surgical procedures for CLM, benign liver lesions and inguinal hernias: Group A: 22 patients with inguinal hernias, Group B: 26 patients with benign liver lesions, Group C: 30 patients with colorectal liver metastases (CLM) who were treated by radiofrequency ablation, Group D: 41 patients with CLM who underwent a radical surgical therapy - resection, and Group E: 22 patients with inoperable CLM who underwent an explorative laparotomy without any surgical procedure. RESULTS: The preoperative and postoperative serum levels of CEA, CA 19-9, TK, TPA, TPS, MMP-2, MMP-9, TIMP-1, and TIMP-2 were statistically analyzed and compared within the groups to estimate the influence of a surgical procedure type. These results reflect the influence of surgical procedure on the serum levels of studied tumour markers during operation. CONCLUSIONS: It was the first description using these types of comparison to all metalloproteinases, their inhibitors, and proliferative and classical tumour markers. It could help us to estimate the critical relations of these tumour markers in prognoses of disease free survival or overall survival in patients after a surgical procedure for CLM (Tab. 5, Ref. 26).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12023996
- 003
- CZ-PrNML
- 005
- 20140827100051.0
- 007
- ta
- 008
- 120815s2012 xo f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4149/bll_2012_025 $2 doi
- 035 __
- $a (PubMed)22394042
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Liska, V $u Department of Surgery, Charles University, Prague, Czech Republic. Vena.Liska@seznam.cz
- 245 10
- $a Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases / $c V. Liska, A. Sutnar, LH. Jr, J. Vrzalova, V. Treska, T. Skalicky, M. Pesta, S. Kormunda, J. Finek, M. Rousarova, O. Topolcan,
- 520 9_
- $a OBJECTIVES: Classical and proliferative tumour markers and matrix metalloproteinases and their tissue inhibitors reflect the features of malignancy and are useful in prediction of prognosis in patients with colorectal liver metastases. There is very limited information about their physiological functions during regeneration and healing of liver parenchyma after any type of liver surgery for malignancy. METHODS: The presented study included the patients, who underwent following surgical procedures for CLM, benign liver lesions and inguinal hernias: Group A: 22 patients with inguinal hernias, Group B: 26 patients with benign liver lesions, Group C: 30 patients with colorectal liver metastases (CLM) who were treated by radiofrequency ablation, Group D: 41 patients with CLM who underwent a radical surgical therapy - resection, and Group E: 22 patients with inoperable CLM who underwent an explorative laparotomy without any surgical procedure. RESULTS: The preoperative and postoperative serum levels of CEA, CA 19-9, TK, TPA, TPS, MMP-2, MMP-9, TIMP-1, and TIMP-2 were statistically analyzed and compared within the groups to estimate the influence of a surgical procedure type. These results reflect the influence of surgical procedure on the serum levels of studied tumour markers during operation. CONCLUSIONS: It was the first description using these types of comparison to all metalloproteinases, their inhibitors, and proliferative and classical tumour markers. It could help us to estimate the critical relations of these tumour markers in prognoses of disease free survival or overall survival in patients after a surgical procedure for CLM (Tab. 5, Ref. 26).
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kolorektální nádory $x patologie $7 D015179
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory jater $x diagnóza $x sekundární $x chirurgie $7 D008113
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matrixové metaloproteinasy $x krev $7 D020782
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a tkáňové inhibitory metaloproteinas $x krev $7 D019714
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sutnar, A
- 700 1_
- $a Jr, L Holubec
- 700 1_
- $a Vrzalova, J
- 700 1_
- $a Treska, V
- 700 1_
- $a Skalicky, T
- 700 1_
- $a Pesta, M
- 700 1_
- $a Kormunda, S
- 700 1_
- $a Finek, J
- 700 1_
- $a Rousarova, M
- 700 1_
- $a Topolcan, O
- 773 0_
- $w MED00000845 $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 113, č. 2 (2012), s. 108-13
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22394042 $y Pubmed
- 910 __
- $a ABA008 $b A 4 $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20140827100434 $b ABA008
- 999 __
- $a ok $b bmc $g 946144 $s 781324
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 113 $c 2 $d 108-13 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
- GRA __
- $a NS10230 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02